The content on this site is intended for healthcare professionals only
Dr Harold Burstein and Prof Richard Schilsky comment on data, during a press conference at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, from the TAILORx trial.
For more on these results, watch Dr Sparano present the data in the press conference, watch his interview with ecancer and read our news coverage here.
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 11th - 17th, 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Choosing Wisely in implementing prevention, screening and early detection programs in Africa
